Doctor calls for more endometriosis research in south London
A south London researcher has said NIHR-supported research into endometriosis is essential to transforming the lives of women affected by the condition.
Endometriosis is where tissue like the womb's lining grows in other places, such as the ovaries and fallopian tubes. The condition can affect women of any age, including teenagers.
The ESPriT2 trial aims to determine if the removal of Superficial Peritoneal Endometriosis (SPE) (deposits on the lining of the abdominal wall) can reduce pain and improve quality of life. Researchers also want to know which method of surgery is more effective or if surgery is of no benefit.
Dr Tom Holland is a Consultant Gynaecologist at Guy's and St Thomas' NHS Foundation Trust. He is also a Principal Investigator for the ESPriT2 trial. The consultant stressed the need for more research into the condition. Tom said:
"Management of endometriosis has not changed for the last 30 years. We urgently need more research into the diagnosis and treatment of endometriosis. Patients are taking part in the trial because they want better treatment options and to make a difference for other women."
Tom also leads a sub-study as part of the ESPRiT2 trial at Guy’s and St Thomas’. He and other researchers are investigating if it is possible to diagnose SPE via ultrasound.
Doctors discover endometriosis via keyhole surgery. If SPE is found, gynaecologists usually remove it during surgery.
The trial team says on the University of Edinburgh’s website that 176 million women worldwide have endometriosis. The condition can lead to debilitating pelvic pain.
The NIHR is the UK's largest funder of health and care research.
You can find out more about the ESPriT2 trial on the University of Edinburgh's website.
